Vault-13

GALAPAGOS NV NPV ISIN BE0003818359 SEDOL B07Q2V5 GLPGF

COMMONSTOCK · Common Stock · CUSIP B44170106

Belgian pharmaceutical company

1 institutional holders +0 vs Q1 2020
286,526286.5k shares reported held*
$56.3mreported value*
0 new 0 added 1 reduced 0 sold out net sold ≈ $72.1m (-366.6k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $196.61.

Trends to Q2 2020

Institutional holders

Managers reporting a position, each quarter

001Q4 19: 1Q1 20: 1Q2 20: 11Q4 19Q1 20Q2 20
Numbers
QuarterHolders
Q4 20191
Q1 20201
Q2 20201

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
101Q1 20: 0 bought or addedQ1 20: 1 cut or sold outQ1 20Q2 20: 0 bought or addedQ2 20: 1 cut or sold outQ2 20
Numbers
QuarterBought or addedCut or sold out
Q1 202001
Q2 202001

Biggest buyers

None

Biggest sellers

GILDER GAGNON HOWE & CO LLC Reduced -366,610-366.6k

Insider purchases and sales in Q2 2020

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

None reported in Q2 2020.

Holders, Q2 2020

#ManagerLocationShares Value% of their portfolioChangeShares change
1 GILDER GAGNON HOWE & CO LLC 0.44% of their portfolio New York, NY 286,526286.5k $56.3m $56.3m 0.44% Reduced -366.6k -366,610